Solar Foods starts Factory01
Finnish Solar Foods Oy has started microbial production of its protein powder Solein in Factory 01, Solar Foods’ first commercial-scale production facility in Vantaa, Finland.
Shock: Adrenomed AG gets FDA fast track designation
German AdrenoMed AG has got FDA Fast Track designation for its targeted septic shock medicine enibarcimab that restores endothel integrity. <br /><br /><br /><br />
Lonza AG enters R&D collaboration with NeuroSense Therapeutics Ltd
ALS specialist NeuroSense Therapeutics Ltd announces it will be collaborating with Swiss Lonza AG to identify exosome-based biomarkers to advance theranostics in neurodegeneration.
Essential Pharma acquires Renaissance Pharma Ltd
Essential Pharma has acquired Renaissance Pharma Ltd to commercialise the company’s Phase II program Hu14.18K322A in pedriatric high-risk neuroblastoma.<br /><br />
Unitaid awards Medincell US$6m to fight malaria
Global health agency Unitaid has awarded French Medincell Corp (Jacou) an extension grant of up to US$ 6 million over three years to fund thesatety testing of its malaria vaccine […]
Genmab broadens ADC pipeline with $1.8bn acquisition of ProfoundBio
Genmab announced today that it will acquire privately held biotech company ProfoundBio for $1.8bn in cash. The deal is designed to help the Danish pharmaceutical company deepen its cancer pipeline […]
TME Pharma gets FDA Fast Track for Glioblastoma
TME Pharma (France/Germany) announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for NOX-A12 (olaptesed pegol), TME Pharma's CXCL12 inhibitor, in combination with radiotherapy and bevacizumab […]
Forbion participates in US financing rounds
Forbion, the European life sciences venture capital firm from The Netherlands, announced its participation in oversubscribed Series B financing in Capstan Therapeutics Inc. and Engrail Therapeutics. Both companies are located […]
New law to speed up clinical trials
With a new law, the German government wants to increase the number of clinical trials conducted in Germany and make the country number one in Europe again.
Gut bacteria seed autoimmunity-inducers
A bacterium of the gut microbiome seems to spark an autoimmune disease in the kidneys by leaking antigens that trigger the immune system.